Scientists test Four-Pronged attack on tough breast cancer
Disease control
Terminated
This study tested four different drug combinations to see if they could help control advanced triple-negative breast cancer that had spread. It involved 24 patients and aimed to see if pairing a drug called olaparib with other targeted medicines, or using a single new drug, could…
Phase: PHASE2 • Sponsor: Gordon Mills, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC